| Literature DB >> 27714525 |
H M Crane1, R M Nance2, J A C Delaney3, R J Fredericksen2, A Church2, J M Simoni4, R D Harrington2, S Dhanireddy2, S A Safren5, M E McCaul6, W B Lober2, P K Crane2, I B Wilson7, M J Mugavero8, M M Kitahata2.
Abstract
Questions remain regarding optimal timeframes for asking about adherence in clinical care. We compared 4-, 7-, 14-, 30-, and 60-day timeframe missed dose items with viral load levels among 1099 patients on antiretroviral therapy in routine care. We conducted logistic and linear regression analyses examining associations between different timeframes and viral load using Bayesian model averaging (BMA). We conducted sensitivity analyses with subgroups at increased risk for suboptimal adherence (e.g. patients with depression, substance use). The 14-day timeframe had the largest mean difference in adherence levels among those with detectable and undetectable viral loads. BMA estimates suggested the 14-day timeframe was strongest overall and for most subgroups although findings differed somewhat for hazardous alcohol users and those with current depression. Adherence measured by all missed dose timeframes correlated with viral load. Adherence calculated from intermediate timeframes (e.g. 14-day) appeared best able to capture adherence behavior as measured by viral load.Entities:
Keywords: Adherence; Depression; Hazardous alcohol use; Substance use; Viral load
Mesh：
Substances：
Year: 2017 PMID： 27714525 PMCID： PMC5290185 DOI： 10.1007/s10461-016-1566-8
Source DB: PubMed Journal: AIDS Behav ISSN： 1090-7165